Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy.

Hongxia Sun Hui Chen James Crespo Guillin Tang Melissa Robinson Bora Lim Ayşegül A Şahin

Published in: European journal of breast health (2021)

Polysomy 17 tumors in different HER2 FISH groups have different pathological features and respond to NACT differently. These results may help us identify patients who will benefit from anti-HER2 therapy.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
rectal cancer
squamous cell carcinoma
radiation therapy
early stage
mesenchymal stem cells